GCL
AGN

Glazer Capital LLC’s Allergan plc AGN Stock Holding History

Glazer Capital LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-285,861
Closed -$50.6M – 238
2020
Q1 		$50.6M Buy
+285,861
New +$53.8M 3.38% 4

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Glazer Capital LLC's AGN Position: Q2 2020 in Review

Glazer Capital LLC sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 285,861 shares — an estimated $50.6M sold.

Glazer Capital LLC first reported a position in AGN in Q1 2020 and held it in 1 quarter. The position peaked at $50.6M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Glazer Capital LLC reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Glazer Capital LLC sold 285,861 Allergan plc shares in Q2 2020, an estimated $50.6M.
  • Glazer Capital LLC first reported a position in Allergan plc in Q1 2020 and held it in 1 quarter.
  • Glazer Capital LLC's Allergan plc position peaked at $50.6M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Glazer Capital LLC's 13F filing for Q2 2020, filed 14 Aug 2020.